Newly recognized syndrome keeps patients from full recovery, researchers say

June 12, 2012

(Medical Xpress) -- University of Florida researchers have identified a medical condition they say keeps many intensive care, heart surgery and burn patients from recovering fully and returning home.

Called persistent inflammation, and catabolism syndrome, or PICS, for short, the newly named condition defies existing treatments and leaves weak and unable to breathe or move properly. Patients generally recover enough from their original illnesses or injuries to be discharged from the hospital, but not enough to return to normal life.

Finding a solution to this enigmatic problem may allow most patients to return to health, and could potentially save billions of dollars in extra each year.

“Hospital mortality is progressively decreasing, but more people are being sent to long-term acute care facilities,” said Dr. Frederick Moore, a professor and chief of acute care surgery in the UF College of Medicine department of surgery. “We’re creating this new population of chronically, critically ill patients.”

Moore and colleagues, including Lyle Moldawer, a professor and vice chairman of research in the department, and Bruce McKinley, a professor of surgery, define and describe the new syndrome in the June 8 edition of the Journal of Trauma and Acute Care Surgery.

In the past, many patients in succumbed to complications such as shock or multiple-organ failure after major or injury and related surgery. Treatment advances now allow most patients to survive those once overwhelming conditions. Still, for many of those patients, PICS is an obstacle to full recovery.

About 250,000 U.S. patients develop PICS each year as a result of severe sepsis, an infection that spreads throughout the body and overwhelms the immune system, the UF researchers estimate. Add to that PICS in other trauma and emergency general surgery patients and the actual number of cases is likely much higher. Extra medical costs associated with intensive and long-term acute care for those patients could reach a $100 billion per year — a conservative estimate — the researchers said.

Moore and colleagues in the departments of surgery and anesthesiology identified the syndrome by analyzing and comparing clinical observations and decades’ worth of immunology research they and others conducted.

The work, funded in part by the National Institute of General Medical Sciences, is the first step toward establishing PICS as a widely recognized condition, the researchers said.

“Further research will be needed to confirm its epidemiology and immune system profile and to identify early predictors so that we can design and study new ways to prevent and treat it,” Moore said.

PICS occurs when the immune system “panics” in response to multiple health threats and releases large numbers of immature immune cells from the bone marrow. These cells have mixed effects on the patient: They cause harmful inflammation and do not protect the body as well as their mature counterparts.

“You have a big surgery that goes fine,” Moore said. “But if you have a complication, and say you develop pneumonia, or an infection at the surgical site, then you have the second hit. It’s this repeated stimulation that causes the bone marrow to release these immature cells.”

Though health care providers usually can help patients avoid major complications such as shock and multiorgan failure, they can’t stop patients’ immune systems from flooding the body with immature immune cells.

Full recovery eludes patients who have PICS because the syndrome drains fuel from the body’s last-resort energy reserve.

“The immune system and all the immune cells require protein and energy and both are coming from structural proteins in the body, such as skeletal muscle,” McKinley said. “Basically, the body is consuming itself.”

Depletion of muscle throughout the body leaves patients increasingly weak, unable to move and breathe well. Replenishing the body with existing nutritional therapies does not coax it to stop cannibalizing its own muscle.

“You can give patients all the good nutrition you have, but their bodies are being told, ‘Break down muscle. Break down muscle.’ That’s what they’re doing,” Moore said.

Medical providers don’t yet know how to treat PICS effectively, but initial attempts to develop successful treatments will build on existing basic therapies and could include special exercise routines and muscle-saving medications. New nutritional therapies that help with wound healing and proper hormone and function could also help the body return to normal.

While researchers seek ways to prevent or effectively treat the syndrome, it continues to inhibit patients’ recovery, with far-reaching negative effects.

“The amount of resources and medical care that’s required by these patients is enormous,” said Dr. Ronald Maier, the Jane and Donald D. Trunkey professor and vice chairman of surgery at the University of Washington. Maier did not contribute to the UF research.

“If we can better understand it, we could then develop therapeutic interventions to minimize it or hopefully help it resolve more quickly.”

Explore further: Researchers to speed up recovery times

Related Stories

Researchers to speed up recovery times

May 3, 2012
Elite athletes and recreational exercisers alike could soon be enjoying quicker recovery times thanks to research into exercise-induced fatigue.

Device helps with Sudden Infant Death Syndrome detection

May 9, 2012
University of Texas at Arlington researchers have obtained a patent for a device aimed at saving babies’ lives through improved and rapid detection of Sudden Infant Death Syndrome.

New tool enhances view of muscles

January 23, 2012
Simon Fraser University associate professor James Wakeling is adding to the arsenal of increasingly sophisticated medical imaging tools with a new signal-processing method for viewing muscle activation details that have never ...

Antibiotics boost risk of infection with antifungal-resistant candida

May 22, 2012
Previous exposure to certain antibiotics could boost the risk of infection with drug-resistant strains of a severe fungal infection. Researchers report their findings in the May 2012 issue of the journal Antimicrobial Agents ...

Equine herpesvirus study to unravel how virus unlocks immune system 'gate'

January 19, 2012
A Colorado State University study will look at how equine herpesvirus type 1 may compromise the immune system immediately upon entering the “gate” of a horse’s respiratory system – the airway and throat ...

Recommended for you

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.